The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ATN INTL INC | COM | 00215F107 | 376 | 9,000 | SH | SOLE | 0 | 9,000 | 0 | 0 | |
BANK NEW YORK MELLON CORP | COM | 064058100 | 4,244 | 100,000 | SH | SOLE | 0 | 100,000 | 0 | 0 | |
EPSILON ENERGY LTD | COM | 294375209 | 5,136 | 1,384,461 | SH | SOLE | 0 | 1,384,461 | 0 | 0 | |
IRIDEX CORP | COM | 462684101 | 3,313 | 1,320,000 | SH | SOLE | 0 | 1,320,000 | 0 | 0 | |
NAVIGATOR HOLDINGS LTD | SHS | Y62132108 | 13,414 | 1,225,000 | SH | SOLE | 0 | 1,225,000 | 0 | 0 | |
NEWMONT CORP | COM | 651639106 | 14,973 | 250,000 | SH | SOLE | 0 | 250,000 | 0 | 0 | |
REATA PHARMACEUTICALS INC | CL A | 75615P103 | 17,307 | 140,000 | SH | SOLE | 0 | 140,000 | 0 | 0 | |
SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 3,739 | 10,000 | SH | SOLE | 0 | 10,000 | 0 | 0 | |
VERSO CORP | CL A | 92531L207 | 1,771 | 147,310 | SH | SOLE | 0 | 147,310 | 0 | 0 | |
WELLS FARGO CO NEW | COM | 949746101 | 755 | 25,000 | SH | SOLE | 0 | 25,000 | 0 | 0 |